Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Biologic Therapy/Immunobiology
•
Rheumatology
•
COVID-19
•
General Rheumatology
•
Tocilizumab
•
Biologics
•
COVID-19 virus
Do you use tocilizumab for the treatment of severe COVID-19 in patients who are on other biologics for rheumatic diseases, such as rituximab?
Related Questions
Can Dupixent (dupliumab) be safely used in patients who are taking other biologics for rheumatic disease?
How do you approach a patient with idiopathic anterior uveitis who has ongoing disease despite adalimumab every two weeks?
In patients with sicca symptoms and positive SSA/SSB how often do you perform other diagnostic testing such as salivary gland ultrasound, biopsy, Shirmers, ocular staining, stimulated salivary flow, etc?
How would you approach management of a patient with ESRD on the transplant list who is found to have high titer APS labs (ACL, B2GP1, LAC)?
How would you approach management of a patient with longstanding history of SLE, but having active psoriasis?
Do you generally utilize calcium channel blockers on an as needed basis for patients with Raynaud's phenomenon?
Do you pursue coronary artery calcium scoring in patients with metabolic risk factors and autoimmune disease in order to guide decisions regarding GLP-1 medications?
Can lupus anticoagulant be positive despite a normal aPTT?
Are there specific conventional DMARDs and/or biologics that are contraindicated in patients with alpha-gal allergy?
How do you approach a patient with elevated bone specific ALP (>2X the normal limit), but no other evidence of Paget's disease?
